Development of LRRC15-binding disulfide-constrained peptides for PET imaging of cancer-associated fibroblasts
17h ago1 min readNews
From the article
Developed peptides, ML-YSD-07 & ML-PD-03, show subnanomolar affinity for muLRRC15, enabling precise PET imaging of CAFs in tumors. High precision, high promise! PMID:42248838, Nat Commun 2026, @NatureComms #Medsky #Pharmsky #RNA #ASHG #ESHG 🧪
Continue reading on doi.orgYou might also wanna read

Antibody-ligand motif optimization enables multitarget switchable CAR-T therapy against solid tumors
This article presents a research study on optimizing a multitarget switchable CAR-T (sCAR-T) strategy to overcome antigenic heterogeneity an
cell.com·12d ago

AI-guided discovery identifies GPNMB as promising CAR T cell target for multiple cancers
Researchers developed an AI-driven framework for discovering CAR T cell therapy targets by integrating single-cell RNA sequencing data from
cell.com·13d ago
Clinical Study of 177Lu-JH040182 in Patients With FAP-Positive Malignancies
clinicaltrials.gov·7d ago
Computational Design of Peptide Masks Enables Conditionally Active Miniprotein Therapeutics
This article presents a novel computational approach for designing conditionally active miniprotein binders through de novo peptide masks. T
AI-Driven Protein Binder Design: Progress and Pitfalls in Evaluation Practices
This article discusses the rapid advancement of de novo protein binder design using AI, including antibodies and nanobodies. While the field
A Study Comparing BL-M07D1 With DS-8201 in Patients With HR-Positive, HER2-Low Expressing Recurrent/Metastatic Breast Cancer
clinicaltrials.gov·8d ago

Comments
Sign in to join the conversation.
No comments yet. Be the first.